AI tool to predict outcomes in pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study uses artificial intelligence to analyze tissue samples from pancreatic cancer to help predict how the disease may progress. It aims to improve treatment planning and patient care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of pancreatic cancer from a biopsy taken during an endoscopic ultrasound procedure.
- You must be able to provide written consent and understand the study.
- You should not have any other active cancers.
- You need to have at least 6 months of follow-up data after diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an artificial intelligence (AI) system can help doctors spot abnormal or cancerous growths in the pancreas during a special endoscopic procedure called pancreatoscopy. If successful, it could improve the accuracy of detecting these growths and help guide treatment decisions.
This trial is testing an artificial intelligence (AI) system that helps doctors identify solid masses in the pancreas using images from a special endoscope (endoscopic ultrasound). The goal is to see if the AI can make a more accurate diagnosis than the standard approach.
This study uses artificial intelligence (AI) to help doctors make better decisions for people with suspected pancreatic conditions. If you are already getting a special CT scan, the AI will analyze the images to see if it can improve diagnosis and treatment planning.
This study tests how well an AI tool can guide which pre-surgery treatment is best for people with pancreatic cancer that can be removed. It uses your tumor's genetic fingerprint to choose the most effective therapy.
This study is testing how well artificial intelligence can help doctors see and understand images from an endoscopic ultrasound. If you are scheduled for this procedure, you may be able to join.
This study is using an artificial intelligence tool called 'PANDA' to look at your existing CT scans to help find or evaluate pancreas conditions. It might help detect problems earlier, so your doctor can act sooner.
Hear when a new Pancreatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.